Exollence will open the future of the biopharmaceutical industry.
-
2022
-
04
Pre-A funding ($2.3M)
-
03
Changed the company name to Exollence Co., Ltd.
-
-
2021
-
05
Moved the R&D Center(#514-515, Mokdong Hospital MCC A)
-
02
Seed funding
-
-
2020
-
07
Received government research grant from Korea Ministry of SMEs and Startup
(Startup Growth Technology Development project, Strategic Startup program) -
05
Received government research grant from Korea Business Angels Association
(TIPS Start-up Commercialization program) -
02
Approved Company affiliated research institute
-
-
2019
-
12
Approved Venture Company
-
11
Received government research grant from Korea Business Angels Association
(Tech Incubator Program for Startup: TIPS program) -
10
Investment by Chungbuk Creative Economy Innovation Center
-
09
Acquisition of Credit Guarantee by Korea Technology Finance Corporation
-
06
Technology transfer assignment (3 cases) from Ewha Womans University
-
05
Found Exollence Co., Ltd.
-